Physician profile

Beverly Blessing

Family · Rancho Mirage, CA

NPI 1982770442

$665.81

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$91.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $389.61 2021-2023
Aspira Women'S Health INC $76.93 2021-2023 Ova1
Evofem Biosciences, INC. $52.14 2021
Hologic Sales and Service, LLC $38.90 2023 Thinprep 2000 Processor
Myovant Sciences INC. $34.03 2021
Pfizer INC. $22.00 2021
Coopersurgical, INC. $18.74 2021
Daiichi Sankyo INC. $17.37 2021
Agile Therapeutics, INC. $16.09 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Beverly Blessing

$665.81

in general payments reported 2019-2025

Years
2021-2023
Top company
Abbvie INC.

https://glasscript.com/doctor/11175041/beverly-blessing

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.